As of 2025-07-12, the EV/EBITDA ratio of NextCure Inc (NXTC) is 0.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NXTC's latest enterprise value is -10.75 mil USD. NXTC's TTM EBITDA according to its financial statements is -63.86 mil USD. Dividing these 2 quantities gives us the above NXTC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-05-13 | 0.15 |
| 2025-05-12 | 0.15 |
| 2025-05-09 | 0.15 |
| 2025-05-08 | 0.17 |
| 2025-05-07 | 0.17 |
| 2025-05-06 | 0.15 |
| 2025-05-05 | 0.14 |
| 2025-05-02 | 0.15 |
| 2025-05-01 | 0.13 |
| 2025-04-30 | 0.14 |
| 2025-04-29 | 0.13 |
| 2025-04-28 | 0.14 |
| 2025-04-25 | 0.14 |
| 2025-04-24 | 0.16 |
| 2025-04-23 | 0.16 |
| 2025-04-22 | 0.17 |
| 2025-04-21 | 0.18 |
| 2025-04-17 | 0.18 |
| 2025-04-16 | 0.19 |
| 2025-04-15 | 0.20 |
| 2025-04-14 | 0.20 |
| 2025-04-11 | 0.21 |
| 2025-04-10 | 0.22 |
| 2025-04-09 | 0.21 |
| 2025-04-08 | 0.20 |
| 2025-04-07 | 0.17 |
| 2025-04-04 | 0.17 |
| 2025-04-03 | 0.17 |
| 2025-04-02 | 0.17 |
| 2025-04-01 | 0.15 |
| 2025-03-31 | 0.13 |
| 2025-03-28 | 0.12 |
| 2025-03-27 | 0.11 |
| 2025-03-26 | 0.11 |
| 2025-03-25 | 0.09 |
| 2025-03-24 | 0.07 |
| 2025-03-21 | 0.09 |
| 2025-03-20 | 0.07 |
| 2025-03-19 | 0.09 |
| 2025-03-18 | 0.09 |
| 2025-03-17 | 0.06 |
| 2025-03-14 | 0.04 |
| 2025-03-13 | 0.03 |
| 2025-03-12 | 0.03 |
| 2025-03-11 | 0.04 |
| 2025-03-10 | 0.02 |
| 2025-03-07 | 0.01 |
| 2025-03-06 | 0.03 |
| 2025-03-05 | 0.02 |
| 2025-03-04 | 0.02 |